DHCG and Altruist Partner to Advance Biologics in China
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
Regulatory Strategy
Advertisement
Dark Horse Consulting and KunTuo Partner to Accelerate CGT Trials
WALNUT CREEK, Calif., and BEIJING, China, May 11, 2026 Dark Horse Consulting Group (DHCG) and KunTuo Medical Research and...
Dark Horse Consulting Group Partners with Porton Advanced for IITs
WALNUT CREEK, CA, USA & SUZHOU, CHINA, April 27, 2026 Dark Horse Consulting Group (DHCG) and Porton Advanced have...
Jupiter Neurosciences Aligns Capital With Clinical Growth
JUPITER, Fla., Feb. 23, 2026 — Jupiter Neurosciences, a clinical-stage pharmaceutical company focused on neuroinflammation and central nervous system...
Santé Ventures Raises $330M to Fund Early-Stage Life Sciences Innovation
AUSTIN, Texas, Feb. 2, 2026 — Early-stage investor Santé Ventures announced the successful close of its fifth and largest...
Advertisements
Hanmi Expands GLP-1 Obesity Drug Reach Through Mexico Deal
SEOUL, SOUTH KOREA | January 27, 2026 — Hanmi Pharmaceutical, the core operating company of Hanmi Science, announced a...
Positive Zoliflodacin Phase 3 Data Published in The Lancet
LONDON, December 12, 2025 — Innoviva Specialty Therapeutics announced the publication of positive Phase 3 clinical results for zoliflodacin...
Atossa Pursues FDA Path for Low-Dose (Z)-Endoxifen in Breast Cancer Prevention
Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company, announced it has filed a request for a Type C...
Advertisement
